Abstract
The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.
Original language | English (US) |
---|---|
Pages (from-to) | 108-126 |
Number of pages | 19 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1325 |
Issue number | 1 |
DOIs | |
State | Published - Sep 1 2014 |
Keywords
- Animal reflux-inflammation models
- Barrett's adenocarcinoma
- Biomarkers
- COXIBs, PPIs
- Elofrnithine
- OESO
- Statins
ASJC Scopus subject areas
- Neuroscience(all)
- Biochemistry, Genetics and Molecular Biology(all)
- History and Philosophy of Science